Table 2 Properties of monoclonal antibodies against PfCP-2.9
From: Epitope mapping of PfCP-2.9, an asexual blood-stage vaccine candidate of Plasmodium falciparum
Designation | Recognition | Reduction sensitivity | GIA (%) | ||
|---|---|---|---|---|---|
PfCP-2.9 | AMA-1 | MSP-1 19 | |||
mAb2G | + | + | - | - | 0 |
mAb6G | + | - | - | + | 0 |
mAb7G | + | + | - | + | 12 |
mAb10G | + | + | - | + | 10 |
mAbG11.12 | + | + | - | + | 0 |
mAb13 | + | - | + | + | 9 |
mAb16 | + | - | + | - | 31 |
mAb17 | + | - | - | - | 20 |
mAb18.20 | + | - | - | - | 0 |
mAbW9.10 | + | + | - | + | 0 |
mAbW17 | + | - | + | + | 32 |
mAbP5-W12 | + | - | + | + | 0 |